Evidence map›Paper›PMID 32190121›Full record

SynthesisCardiovascular therapeutics2020

Effects of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Xiuli Li, Peng Chang, Qiongying Wang, Hao Hu, Feng Bai, Ningyin Li, Jing Yu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cardiovascular therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Clinical research progress in pulse wave velocity in the assessment of vascular aging.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Vascular Aging: Assessment and Intervention.Clinical interventions in aging · 2023
    Review
  10. Review
  11. Article
  12. MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Review
  13. Article
  14. ACE2 enhance viral infection or viral infection aggravate the underlying diseases.Computational and structural biotechnology journal · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiuli LiDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.
Peng ChangDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.
Qiongying WangDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0002-5497-3196
Hao HuDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.
Feng BaiDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.
Ningyin LiDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.
Jing YuDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0003-2234-8959
Lanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine the effects of ACEIs on arterial stiffness, a meta-analysis of randomized controlled trials was conducted. Relevant articles that investigated the effects of ACEIs on arterial stiffness from PubMed, Embase, and the Cochrane library from inception to September 2018 were systematically retrieved. The investigated outcomes included brachial-ankle pulse wave velocity (ba-PWV) and carotid-femoral PWV (cf-PWV) by using weighted mean differences (WMDs) and 95% confidence intervals (CIs) with the random-effects model. A total of 17 RCTs including 1,458 individuals were included. The summary results indicated no significant differences between ACEIs and control for ba-PWV and cf-PWV. Also, no significant differences between ACEI and control for ba-PWV and cf-PWV were observed in hypertensive patients, while the therapeutic effects of ACEI versus placebo showed statistically significant difference. Moreover, subgroup analysis indicated that the levels of ba-PWV were significantly associated if the study was conducted in Western countries, mean age <60.0 years, percentage male ≥60.0%, compared with ARBs, baseline PWV <10.0, and high-quality study. Furthermore, the significant levels of cf-PWV in patients who received ACEIs were observed when percentage male was ≥60.0% and the studies were of high-quality. Finally, no significant differences were observed between ACEIs and other antihypertensive drugs regarding the changes of systolic blood pressure (SBP) and diastolic blood pressure (DBP). The overall analysis suggested no significant differences between ACEIs and other antihypertensive drugs for ba-PWV and cf-PWV levels, whereas ACEIs versus placebo showed lower levels of ba-PWV and cf-PWV.

Indexed as

AdultAgedAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBlood PressureCarotid-Femoral Pulse Wave VelocityFemaleHumansHypertensionMaleMiddle AgedRandomized Controlled Trials as TopicRisk FactorsTreatment OutcomeVascular StiffnessAngiotensin-Converting Enzyme InhibitorsAntihypertensive Agents

Identifiers

PMID32190121
PMCPMC7068147
OpenAlexW3008836866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.